6SURI M F, HUSSEIN H M, ABDELMOULA M M, et al. Safety and tolerability of 600 mg clopidogrel bolus in patients with acute ischemic stroke:preliminary experience [J].Med Sci Monit,2008,14(10) :139-144.
7ROTHWELL P M, GILES M F, CHANDRATHEVA A, et al.Effect of urgent treatment of transient ischaemic attack and minorstroke on early recurrent stroke (EXPRESS study ) : a prospective population- based sequentialcomparison I- J .Lancet, 2007,370(9596) : 1432-1442.
8MEHTA S R, TANGUAY J F, EIKELBOOM J W, et al. Double-dose versus standard- dose clopidogrel and high- dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes(CURRENT -OASIS 7):a randomised factorial trial [ J ]. Lancet, 2010,376 ( 9748 ) : 1233-1243.
9DIEDLER J,AHMED N, SYKORA M, et al. Safety of intra- venous thrombolysis for acute ischemic stroke in patients receiving antiplatelet therapy at stroke onset [ J ]. Stroke, 2010,41 (2) :288-294.
10SANAK D,KULIHA M,HERZIG R,et al.Prior use of anti- platelet therapy can be associated with a higher chance for early recanalization of the occluded middle cerebral artery in acute stroke patients treated with intravenous thrombolysis[ J] .Eur Neurol,2012,67( 1 ) :52-56.
2BHATT D L, SCHEIMAN J, ABRAHAM N S, et al. ACCF / ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use [J]. Am J Gastroenterol,2008,103 ( 11 ) :2890-2907.
3CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events(CAPRIE) [ J]. Lancet, 1996,348 (10) : 1329-1339.
